PTCB Guide to ARBs
Also called Angiotensin II receptor blockers · suffix -sartan · updated
Quick answer
- Mechanism: ARBs block angiotensin II from binding to the AT1 receptor, which relaxes blood vessels and lowers blood pressure. ACE inhibitors instead block the formation of angiotensin II.
- High-yield point: ARBs (the -sartan drugs) treat hypertension and heart failure and usually do not cause the dry cough seen with ACE inhibitors, because they do not raise bradykinin.
- Key cautions: ARBs still raise potassium (hyperkalemia) and carry a boxed Fetal Toxicity warning, so they are treated as contraindicated in pregnancy.
What gets tested
- Recognizing the -sartan suffix and matching brand to generic (Cozaar is losartan, Diovan is valsartan)
- That ARBs block angiotensin II at the AT1 receptor, while ACE inhibitors block its formation
- The high-yield ACE-versus-ARB point: ARBs do not typically cause the dry cough
- That ARBs carry a boxed Fetal Toxicity warning (treated as contraindicated in pregnancy) and can cause hyperkalemia
- Common indications: hypertension, heart failure, and diabetic kidney disease
What is not tested
You are not expected to make prescribing decisions. Choosing which ARB a patient should receive, deciding how quickly to titrate a dose, and reciting the detailed enzyme biochemistry of the renin-angiotensin-aldosterone system all sit outside the technician role, as does comparative clinical trial data. Strengths and durations are not off limits, though: PTCE knowledge area 1.4 covers strengths and dose, dosage forms, routes of administration, special handling and administration instructions, and duration of drug therapy. So you should know that ARBs are oral tablets taken long term, usually once daily (losartan and valsartan may be dosed twice daily), with or without food. What the exam leans on hardest is recognition of the class, brand-to-generic matching, the ACE-inhibitor comparison, common side effects, interactions, and counseling points.
Why arbs matter
Losartan ranks among the top 10 most dispensed medications in the United States, and ARBs appear constantly in the Medications domain alongside ACE inhibitors. Knowing how the two classes differ, especially the cough point, is one of the highest-yield comparisons on the exam.
ARBs at a glance
| Generic | Brand | Primary indication |
|---|---|---|
| losartan | Cozaar | high blood pressure, diabetic kidney disease |
| valsartan | Diovan | high blood pressure, heart failure, after heart attack |
| olmesartan | Benicar | high blood pressure |
| irbesartan | Avapro | high blood pressure, diabetic kidney disease |
| candesartan | Atacand | high blood pressure, heart failure |
| telmisartan | Micardis | high blood pressure, cardiovascular risk reduction (brand Micardis tablets are discontinued in the US; generic telmisartan and Micardis HCT are still available) |
| azilsartan | Edarbi | high blood pressure |
| eprosartan | Teveten | high blood pressure (brand Teveten and generic eprosartan are discontinued in the US and are no longer dispensed) |
Mechanism of action
ARBs selectively block angiotensin II from binding to the angiotensin II type 1 (AT1) receptor. Angiotensin II normally makes blood vessels constrict and triggers aldosterone release, both of which raise blood pressure. By blocking the receptor, ARBs relax blood vessels, lower aldosterone, and reduce blood pressure. This differs from ACE inhibitors, which block the enzyme that converts angiotensin I into angiotensin II: ARBs block the hormone's action at the receptor rather than its formation. Because ARBs do not raise bradykinin levels, they usually do not cause the dry cough associated with ACE inhibitors. The ARBs you are likely to see on the exam and in the pharmacy are losartan, valsartan, olmesartan, irbesartan, candesartan, telmisartan, and azilsartan. Eprosartan (Teveten) is also FDA-approved but is no longer marketed in the United States.
Common and important side effects
- Hyperkalemia (high blood potassium)
- Hypotension and dizziness, especially after the first dose
- Reduced kidney function, particularly with dehydration or renal artery stenosis
- Headache and fatigue
- Angioedema and cough are possible but much less common than with ACE inhibitors
Key interactions
- Potassium-sparing diuretics, potassium supplements, and potassium-containing salt substitutes raise the risk of hyperkalemia
- Lithium levels can rise, increasing the risk of lithium toxicity, so levels are monitored
- NSAIDs can blunt the blood-pressure-lowering effect and increase the risk of kidney injury, especially with a diuretic on board
- Combining an ARB with an ACE inhibitor or with aliskiren (dual blockade of the renin-angiotensin system) raises the risk of hyperkalemia, hypotension, and kidney problems and is generally avoided. Aliskiren is contraindicated with ARBs in patients with diabetes.
Patient counseling notes
- ARBs carry a boxed Fetal Toxicity warning and are stopped as soon as pregnancy is detected: tell the pharmacist right away if you are pregnant or may become pregnant
- Report swelling of the face, lips, or tongue, or trouble breathing, which can signal rare angioedema
- Avoid potassium supplements and salt substitutes that contain potassium unless the prescriber approves
- Rise slowly from sitting or lying down to limit dizziness, especially when starting therapy
- ARBs are a common alternative for patients who developed a dry cough on an ACE inhibitor
Practice questions
Then test the whole class in context with the drug class identification quiz and the brand and generic quiz.
1. A prescription is written for Diovan. Which generic drug should the technician expect to dispense?
- A. Lisinopril
- B. Valsartan ✓
- C. Losartan
- D. Atenolol
Answer: B. Diovan is the brand name for valsartan, an ARB used for hypertension and heart failure. Losartan is also an ARB but is sold as Cozaar, while lisinopril is an ACE inhibitor and atenolol is a beta blocker.
2. How do ARBs lower blood pressure?
- A. They block the enzyme that converts angiotensin I to angiotensin II
- B. They block angiotensin II from binding to the AT1 receptor ✓
- C. They inhibit HMG-CoA reductase
- D. They block beta-1 receptors in the heart
Answer: B. ARBs block angiotensin II at the AT1 receptor, preventing vasoconstriction and aldosterone release. ACE inhibitors act earlier by blocking the enzyme that forms angiotensin II.
3. A patient developed a persistent dry cough while taking the ACE inhibitor lisinopril, so the prescriber switches them to losartan. Why are ARBs less likely to cause this cough?
- A. ARBs are taken at night
- B. ARBs do not raise bradykinin levels ✓
- C. ARBs are not absorbed in the stomach
- D. ARBs lower potassium
Answer: B. The ACE-inhibitor cough is linked to a buildup of bradykinin. ARBs act at the receptor and do not raise bradykinin, so they rarely cause the cough, which is why intolerant patients are often switched to an ARB.
4. Which condition is a contraindication to ARB therapy?
- A. Pregnancy ✓
- B. High cholesterol
- C. Seasonal allergies
- D. Mild acne
Answer: A. ARBs carry a boxed Fetal Toxicity warning and are treated as contraindicated in pregnancy, the same class safety concern seen with ACE inhibitors. The drug is stopped as soon as pregnancy is detected, and a patient who is or may become pregnant should notify the pharmacy.
5. A patient taking valsartan is also prescribed a potassium-sparing diuretic. Which lab value should be monitored most closely?
- A. Blood glucose
- B. Potassium ✓
- C. White blood cell count
- D. Uric acid
Answer: B. ARBs raise potassium, and combining one with a potassium-sparing diuretic or potassium supplement further increases the risk of hyperkalemia, so serum potassium should be monitored.
Cheat sheet
- Suffix: -sartan
- Class: angiotensin II receptor blockers (ARBs)
- Blocks: angiotensin II at the AT1 receptor (ACE inhibitors block its formation)
- Uses: hypertension, heart failure, diabetic kidney disease
- No dry cough like ACE inhibitors, but they still cause hyperkalemia
- Boxed Fetal Toxicity warning: treated as contraindicated in pregnancy
- Watch: potassium, lithium, NSAIDs, and avoid combining with an ACE inhibitor or aliskiren
Related drug-class guides
Official sources
- StatPearls: Angiotensin II Receptor Blockers (NBK537027)
- MedlinePlus: Losartan drug information
- DailyMed: Diovan (valsartan) FDA label
- ClinCalc DrugStats: Losartan (rank 8 of the top 200 drugs, 2023 data)
- FDA Drugs@FDA: Micardis (telmisartan) NDA 020850 marketing status
- FDA Drugs@FDA: Teveten (eprosartan mesylate) NDA 020738 marketing status
- Federal Register: MICARDIS tablets listed in the Orange Book Discontinued Drug Product List
PTCB Quiz Prep is an independent study resource, not affiliated with the Pharmacy Technician Certification Board. This guide is for exam preparation, not medical advice. See our editorial standards. Part of the PTCB Medications domain.
